These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 4078998

  • 1. [A pharmacokinetic study of cefoperazone during percutaneous transhepatic cholangial catheterization].
    Suwa T, Toyama N, Hirakata S, Suzuki F, Oki A, Sato T, Miyoshi K, Sakimura K, Kurane R, Sakai H.
    Jpn J Antibiot; 1985 Aug; 38(8):2033-44. PubMed ID: 4078998
    [Abstract] [Full Text] [Related]

  • 2. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
    Koizumi M, Simosegawa T, Yanbe M, Goto Y, Sugawara H, Kanno Y, Kanazawa Y, Kai Y, Sato T, Endou K.
    Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
    [Abstract] [Full Text] [Related]

  • 3. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice].
    Matsumoto T, Moriwaki M, Iizuka Y.
    Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of cefoperazone in liver diseases].
    Kakiuchi S, Tagawa S, Tameda Y, Kosaka Y.
    Jpn J Antibiot; 1985 Aug; 38(8):2026-32. PubMed ID: 4078997
    [Abstract] [Full Text] [Related]

  • 5. [Clinical studies with cefoperazone in the biliary disease].
    Morinaga T, Furukawa M, Nakata T, Yamada R, Itoh S, Maeda S, Itose K, Ohtsubo M.
    Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972
    [Abstract] [Full Text] [Related]

  • 6. Biliary excretion and pharmacokinetics of cefoperazone in humans.
    Kemmerich B, Lode H, Borner K, Belmega D, Jendroschek T, Koeppe P, Goertz G.
    J Antimicrob Chemother; 1983 Jul; 12(1):27-37. PubMed ID: 6619045
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Yoshida M, Ichikawa Y, Kido M, Ninomiya K, Kitahara Y, Hara N, Tsurutani H.
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [Abstract] [Full Text] [Related]

  • 8. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [Abstract] [Full Text] [Related]

  • 9. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
    Fujii R, Meguro H, Arimasu O, Mashiko J, Tajima T, Nonaka C, Nagamatsu I, Sato Y, Honjo T, Watanabe A.
    Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience with cefoperazone in respiratory tract infections and studies on its penetration into pleural effusion].
    Kajiki A, Yamazaki H, Hasegawa O, Nakashima Y, Kuroiwa A, Harada S, Kido M, Iida K.
    Jpn J Antibiot; 1983 Dec; 36(12):3456-62. PubMed ID: 6674553
    [Abstract] [Full Text] [Related]

  • 11. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S, Sato Y, Iwasaki Y, Hayano S, Wakabayashi R, Kojima Y, Akita H, Sunakawa K, Oikawa T, Osano M.
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [Abstract] [Full Text] [Related]

  • 12. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Cho N, Watanabe H, Yoshida K, Moriyama S, Takeda H, Tsukamoto A, Fukunaga K, Kunii K.
    Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873
    [Abstract] [Full Text] [Related]

  • 13. The effects of biliary obstruction on excretion of cefoperazone in the rat.
    Fabre J, Rudhardt M, Dayer P, Trimble ER, Malè PJ.
    Arzneimittelforschung; 1984 Oct; 34(7):789-91. PubMed ID: 6541914
    [Abstract] [Full Text] [Related]

  • 14. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.
    Leung JW, Chan RC, Cheung SW, Sung JY, Chung SC, French GL.
    J Antimicrob Chemother; 1990 Mar; 25(3):399-406. PubMed ID: 2187012
    [Abstract] [Full Text] [Related]

  • 15. Effect of a bacterial lipopolysaccharide on biliary excretion of a beta-lactam antibiotic, cefoperazone, in rats.
    Haghgoo S, Hasegawa T, Nadai M, Wang L, Nabeshima T, Kato N.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2258-61. PubMed ID: 8619579
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of cefoperazone concentration in human lung tissue].
    Monden Y, Fujimoto Y, Nakahara K.
    Jpn J Antibiot; 1986 Jan; 39(1):57-62. PubMed ID: 3702062
    [Abstract] [Full Text] [Related]

  • 17. [Clinical studies on cefoperazone treatment for bile duct infections (author's transl)].
    Hirayama T, Kikuchi K.
    Jpn J Antibiot; 1981 Jun; 34(6):934-8. PubMed ID: 6457179
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cefoperazone: a review.
    Craig WA, Gerber AU.
    Drugs; 1981 Jun; 22 Suppl 1():35-45. PubMed ID: 6456890
    [Abstract] [Full Text] [Related]

  • 19. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
    Hidaka K, Yamamoto H, Harada S, Katano M, Fujiwara H, Mizoguchi T, Hisatsugu T, Yamaoka K, Kisu T.
    Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
    [Abstract] [Full Text] [Related]

  • 20. [Concentration of antibiotics (cefoperazone) in human brain, brain tumor tissue and cerebrospinal fluid].
    Ito H, Funaki N, Kitamura Y, Shoin K, Nagatani H, Yamamoto S.
    No Shinkei Geka; 1984 May; 12(6):681-6. PubMed ID: 6087180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.